| P2093 | author name string | K Dalhoff | |
| P2860 | cites work | Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine | Q22250891 |
| | The 2009/2010 pandemic | Q30396964 |
| | New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality | Q37433579 |
| | Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors | Q43906376 |
| | CRB-65 predicts death from community-acquired pneumonia. | Q52932226 |
| | Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia | Q55966607 |
| | Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie – Update 2009 | Q56637521 |
| | Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia | Q57238018 |
| | Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment | Q58988112 |
| | Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia | Q64028020 |
| | Invasive aspergillosis in critically ill patients without malignancy | Q80269940 |
| P433 | issue | 9 | |
| P304 | page(s) | 1032, 1034-7 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Die Innere Medizin | Q1194574 |
| P1476 | title | [Community-acquired pneumonia] | |
| P478 | volume | 52 | |